These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 11386498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.
    Hirschmann S, Dannon PN, Iancu I, Dolberg OT, Zohar J, Grunhaus L.
    J Clin Psychopharmacol; 2000 Oct; 20(5):556-9. PubMed ID: 11001241
    [Abstract] [Full Text] [Related]

  • 6. Effect of fluvoxamine on panic disorder.
    Hoehn-Saric R, McLeod DR, Hipsley PA.
    J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder.
    Nair NP, Bakish D, Saxena B, Amin M, Schwartz G, West TE.
    Anxiety; 1996 Oct; 2(4):192-8. PubMed ID: 9160622
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone.
    de Beurs E, van Balkom AJ, Lange A, Koele P, van Dyck R.
    Am J Psychiatry; 1995 May; 152(5):683-91. PubMed ID: 7726307
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder.
    Black DW, Wesner R, Bowers W, Gabel J.
    Arch Gen Psychiatry; 1993 Jan; 50(1):44-50. PubMed ID: 8422221
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.
    McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH.
    Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290
    [Abstract] [Full Text] [Related]

  • 20. Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care.
    Sharp DM, Power KG, Simpson RJ, Swanson V, Anstee JA.
    Br J Gen Pract; 1997 Mar; 47(416):150-5. PubMed ID: 9167318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.